Trius Therapeutics (TSRX) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. This stock closed up 7.4% to $5.28 on Tuesday.
Tuesday's Range: $4.96-$5.29
52-Week Range: $4.41-$6.49
Volume: 1.29 million
Three-Month Average Volume: 382,453
From a technical perspective, TSRX soared higher here right off its 50-day moving average of $4.97 with monster upside volume. This move filled a previous gap down level from a few weeks ago that started at $5.20. Shares of TSRX are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if TSRX manages to clear its 200-day at $5.37 and then once it takes out more resistance at $5.60 with high volume.
Traders should now look for long-biased trades in TSRX as long as it’s trending above its 50-day at $4.97 and then once it sustains a move or close above those breakout levels with volume that hits near or above 382,453 shares. If that breakout hits soon, then TSRX will set up to re-test or possibly take out its next major overhead resistance levels at $5.90 to $5.93. Any move above those levels will then put $6.20 to $6.46 into focus for shares of TSRX.